See more : Olympic Steel, Inc. (ZEUS) Income Statement Analysis – Financial Results
Complete financial analysis of InnovAge Holding Corp. (INNV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InnovAge Holding Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Firm Capital Mortgage Investment Corporation (FC.TO) Income Statement Analysis – Financial Results
- Strategic Minerals Plc (SML.L) Income Statement Analysis – Financial Results
- Chee Corp. (ECRP) Income Statement Analysis – Financial Results
- Zhongfu Information Inc. (300659.SZ) Income Statement Analysis – Financial Results
- MINISO Group Holding Ltd (9896.HK) Income Statement Analysis – Financial Results
InnovAge Holding Corp. (INNV)
About InnovAge Holding Corp.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,850 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 763.86M | 688.09M | 698.64M | 637.80M | 567.19M | 465.63M |
| Cost of Revenue | 631.79M | 586.80M | 563.27M | 463.72M | 425.89M | 355.00M |
| Gross Profit | 132.06M | 101.29M | 135.37M | 174.08M | 141.30M | 110.63M |
| Gross Profit Ratio | 17.29% | 14.72% | 19.38% | 27.29% | 24.91% | 23.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 111.34M | 115.64M | 101.65M | 132.33M | 58.48M | 48.25M |
| Selling & Marketing | 24.96M | 19.63M | 24.20M | 22.24M | 19.00M | 16.46M |
| SG&A | 136.29M | 135.26M | 125.85M | 154.57M | 77.48M | 64.71M |
| Other Expenses | 18.95M | 124.00K | 13.92M | 30.51M | 12.21M | 6.24M |
| Operating Expenses | 155.24M | 150.68M | 139.78M | 185.07M | 89.69M | 70.95M |
| Cost & Expenses | 787.04M | 737.48M | 703.05M | 648.79M | 515.58M | 425.96M |
| Interest Income | 0.00 | 1.52M | 2.53M | 16.79M | 14.62M | 9.59M |
| Interest Expense | 4.02M | 1.52M | 2.53M | 16.79M | 14.62M | 9.59M |
| Depreciation & Amortization | 18.95M | 20.02M | 13.92M | 12.29M | 11.29M | 9.00M |
| EBITDA | 1.15M | -29.25M | 9.21M | -5.89M | 61.54M | 45.92M |
| EBITDA Ratio | 0.15% | -4.92% | 1.32% | 1.35% | 10.85% | 10.12% |
| Operating Income | -23.18M | -49.40M | -4.71M | -3.70M | 50.93M | 39.68M |
| Operating Income Ratio | -3.03% | -7.18% | -0.67% | -0.58% | 8.98% | 8.52% |
| Total Other Income/Expenses | 1.36M | -1.40M | -2.83M | -22.63M | -15.30M | -14.29M |
| Income Before Tax | -21.82M | -50.79M | -7.24M | -34.97M | 35.63M | 25.39M |
| Income Before Tax Ratio | -2.86% | -7.38% | -1.04% | -5.48% | 6.28% | 5.45% |
| Income Tax Expense | 1.40M | -7.24M | 723.00K | 9.77M | 9.87M | 6.32M |
| Net Income | -21.34M | -40.67M | -7.96M | -44.74M | 26.28M | 19.58M |
| Net Income Ratio | -2.79% | -5.91% | -1.14% | -7.01% | 4.63% | 4.20% |
| EPS | -0.16 | -0.30 | -0.06 | -0.33 | 0.20 | 0.15 |
| EPS Diluted | -0.16 | -0.30 | -0.06 | -0.33 | 0.20 | 0.15 |
| Weighted Avg Shares Out | 135.90M | 135.59M | 135.52M | 135.52M | 133.19M | 133.19M |
| Weighted Avg Shares Out (Dil) | 135.90M | 135.59M | 135.52M | 135.52M | 133.19M | 133.19M |
InnovAge Holding Corp. (INNV) Q1 2025 Earnings Call Transcript
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024
InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services
InnovAge Holding Corp. (INNV) Expected to Beat Earnings Estimates: Should You Buy?
InnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual Conference
UPDATE – Leading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by Seniors
Leading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by Seniors
InnovAge Holding Corp. (INNV) Q4 2024 Earnings Call Transcript
InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates
Source: https://incomestatements.info
Category: Stock Reports